A NEW MODEL FOR COLLABORATIVE CLINICAL RESEARCH
IN ONCOLOGY

WE ARE AN INTERNATIONAL, INNOVATIVE, RESEARCH ORGANIZATION IN CLINICAL ONCOLOGY. OUR GOAL IS TO GENERATE THE MOST INNOVATIVE CLINICAL TRIALS WITH THE MOST PROMISING DRUGS BY FOSTERING GLOBAL COLLABORATIONS BETWEEN EXPERT CLINICAL INVESTIGATORS/KOLs AND PHARMACEUTICAL COMPANIES/BIOTECHS.

WE CONNECT THE BEST TREATMENTS WITH THE BRIGHTEST MINDS

MEDSIR is a company founded by scientific experts in 2012. We are dedicated to the design and management of strategic clinical trials in oncology, from study conception to the publication of study results.

MEDSIR favors a collaborative approach for clinical development that aims to combine the highest scientific value with the strategic development of novel cancer treatments, with the final goal of benefiting cancer patients worldwide. Our goal is to generate win-win scenarios for all stakeholders involved in independent clinical research.

TOGETHER WE CAN BUILD A BRIGHTER FUTURE

WHAT WE DO

Our international team of high-level clinicians and research experts are passionate about collaborating with medical oncologists and pharmaceutical companies to develop the best treatments for patients as quickly as possible.